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lable 1. DR, DQ and DP β Chains from a Panel of DRw8 Β
Cell Lines
VvÜD~~Cell Name DR/Dw DQ* DP1 DRß DQß DPß
~jßÖ<S6~ΤΑΒ089 w8/DB7 wl 7 ßl ßl ß~4
#9067 BTB w8/w8 νΛ_ 4 ßl (32 ß5
#9068 BM9 w8/w8 _w4_ 2B1» ßl ß2 ß2
#9069 MADURA w8/w8 w4 4 ßl ß2 ß5
#9070 LUY w8/8 3 w7 1,4 ßl ß3 ß3,ß5
#9071 OLGA w8/8 2 w £ 3 ,4 ' ß2 ß2 ß2,ß4
#9072 SPACH w8/8 2 w4 4B"> ß2 ß2 ß4
#9100 OLL w8/ w4_ 3 4B> ß2 ß2 ß4
+DQ types locally determined, ^DP types by Eckeis
( TAB", DRß 1/DQß 1) or DQw3 ("LUY", DRßl/
DQß3) The "OLGA" type (DRß2/DQß2) might be
generated by mutaüons of DRßl into DRß2 from "BTB"
since both DR β chains carry the DRw8 epitope and are
most hkely evolutionally related
Another interesting finding IS that four different
DR/DQ haplotypes perfectly correlated with HLA D
lypes, "TAB" correlated with DB7, "BTB" with Dw8,
LUY" with Dw8 3, and "OLGA" with Dw8 2 In
the pnmary MLR in one combination of these HTC
cells, DR molecules are different and may be stimula-
tory to each other, while in another combination DQ
molecules are different and may be stimulatory Thus,
DQ molecules as well as DR molecules appear to be
responsible for the HLA D specificity on the DRw8
carrying haplotype
These DR/DQ haplotypes were found differently with
one or two DP molecules isolated by B7/21 The tenta-
tive nomenclature was given to these DP molecules as
previously published (2), where five distinct DP β
chains (DPßl-DPß5) were descnbed Four DPß chains
(DPß2-DPß5) were identified (Table 1) Α correla-
tion between DPß5 and the cellularly defmed DPw4
antigen was confirmed However, the other three DP β
chains were not correlated with any DP antigens in this
study
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Identification of a Cellularly Defined DRW8 Subtype
Μ Bonneville, J F Moreau, Μ L Cheneau, F Bonneville, Ε Blokland, J Pool, Ε Goulmy,
J D Bignon, JY Muller, and J Ρ Souhllou
Cellular mechanisms involved in the allograft rejection
piocess remain highly controversial Using monoclonal
antibodies. several studies have demonstrated convmc
mgly that most oi the infiltrating mononuclear cells are
Τ lymphocytes Moreover, several investigators have
developed techniques for oulturmg Τ cells out of vanous
human allografts in order to delmeate functions of
intragraft Τ cell populations
From a rejected human kidney graft a limiting dilu-
tion technique (1) was used to clonc a large number of
graft invading cells wi'h clonal efhuency of 1/Π Outof
55 clones, 20 were tcsted for 1) prohferative activity in
pi mied lymphocyte typing (PLT), 2) cytotoxic activity in
cell-mediated lympholysis (CML), and 3) cytotoxic
activity mhibited by monoclonal antibodies (MAb) Α
large panel of well HLA-defined cells (PBL PHA-blasts,
and Β lymphoblastoid cell lines-LCL) were used as
stimulator or target cells This panel mcluded all DRW8
positive cells from Workshop homozygous Β LCL (BM9,
TAB 089, MADURA, BTB, OLGA, LUY, S PACHEO,
OLL, SPL), seven heterozygous DRW8 positive cells
from Blood Bank of Leiden (Netherlands), and cells
from recipient BER (DR2 DRW6) and donor DAB
(DR5-DRW8) The following MoAbs were used to
inhibit cytotoxicity expenments against donor-BLCL
W6 32, LEU 10, NDS 10, 1A3, B7/21, 2D6, GSP 4 1
NDS 13 UK 8 1, CHE 249 2, MAD 88 (all Workshop
reagents), and BT 2 9 (anti class II), Dl 12 (anti DR)
VI 15 (anti DR), and BM 50 (anti DR)
Clone "1D9" was selected for lts ability to proliferate
with and to kill only but not all cells beanng DRW8
phenotype (Table 1) This clone was significantly
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Table 1. Prohferative and Cytotoxic Activmes of Clone 1D9
Stimulators (PTL)
or Targets (CML)
Le #15 (BLCL)
Le #16 (BLCL)*
Le #24 (PHA
blasts)
Le #26 (PHA
blasts)
Le #28 (PHA
blasts)
Le #29 (PHA
blasts)
Le #31 (BLCL)*
LUY (Workshop)
(BLCL)
BER (retipient
BLCL)
DAB (donor
BLCL)
HLA
DR/DQ
7-W8/W2
1 W8/W1
W8-W13/W1
1-W8/W1
W8-W14/W1
W8-W13/W1
3-W8/W2
W8/W3
2-W14/W1
5-W8/W3
Clone 1D9
Responder/Effector
mPLT
(cpm)*
21040
3285
]0383
11010
10121
13327
5055
18573
2100
20600
in CML
(% lysis)t
25/22
-/
-/
/
/
/
-/-
24/12
/
16/17
*Results expressed as mean (tnphcate) cpm of 3H-TdR uptake
of clone cultured 72 hours with stimulating cells, '% specific
51 Cr release calculated at two effector/target ratlos (20 1/4 1),
* Leiden #16 and #31 were not recognized by 1D9
inhibited by broad anti-class II and antl-monomoφhlc
DR MoAb, but not by anti-DQ or anti-DP MoAb Mono-
clonal antibody MAD 88 (anti-DRW8) elicited against
DRW8 positive cell MADURA, which was lysed by
clone "1D9," did not block "1D9" cytotoxicity directed
against donor cell DAB (DRW8 positive) But this anti-
body labeled in lmmunofluorescence the Leiden #16 cell
(DRW8 positive), which in lts turn was not lysed by
"1D9," clearly suggesting that "1D9" and MoAb MAD
88 recognized two different epitopes on the β chain of
the DRW8 molecule
In order to identify at the DNA level ihis cellularly
defined DRW8 subtype, a restnction fragment length
polymorphism (RFLP) study was carned out to distin-
guish a DNA polymorphism of these DRW8 cells accord-
mg to their sensitivity to clone "1D9 " Genomic DNAs
from nine DRW8 positive homozygous Workshop cells,
from two recognized heterozygous DRW8 positive cells
(Leiden #15 and donor DAB), and from a non-recog-
mzed heterozygous DRW8 positive cell (Leiden #16)
were digesied with Eco RI, Bam HI, Taq I, and Hind III
dnd then hybndized with Workshop DR ß, DQ α, and
DQ β probes With DR β probe and all enzymes tested,
DRW8 haplotype revealed a charactenstic pattern dis-
tinct from those of others DR specificities Moreover a
specific fragment of 8 9 Kb was noted with Taq 1 But no
polymorphism was found at the DNA level because the
same RFLP pattern was observed for all DRW8 positive
cells includmg the non-recognized Leiden #16 cell All
the restnction enzyme used to hybndize the DQ α and
DQ β probes revealed three different DQ patterns These
results were concordant with those previously reported
by serology (2)
In summary, clone 1D9 specific for the kidney donor
cells IS described It killed neither K562 nor autolo-
gous BLCL On a large panel of well HLA-charactenzed
cells it recognized a majonty of DRW8 positive cells
(15/17 cells) On the other hand, all DRW8 negative
cells (N = 22) were not recognized Prohferative and
cytotoxic activities were concordant RFLP analysis
of DRW8 positive cells either recognized or not by
1D9 did not revealed differences with DR β probe
Hybridization with DQ α and DQ β probes exhibited
three different patterns without any relationship to 1D9
reactivity 1D9 T-cell clone might be directed against
a DRW8 subtype which would need further mvesti-
gations (other restnction enzymes and probes) at the
DNA level Alternatively, the DRW8 molecule might
be the restnction element for some yet unknown minor
alloantigens
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